We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 of the best UK growth, value and dividend shares to consider in an ISA!

Looking for top UK shares to buy in a Stocks and Shares ISA? Royston Wild reveals three top growth, value and dividend stocks from his portfolio.

| More on:
Mixed-race female couple enjoying themselves on a walk

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

The UK stock market’s awash with top-quality shares for long-term investors. Whether you’re looking for growth, value or dividends, there are hundreds of top stocks available to build a five-star portfolio.

Let me reveal three top shares I think Stocks and Shares ISA holders should consider today: CRH (LSE:CRH), Aviva (LSE:AV.) and Primary Health Properties (LSE:PHP). I’ve put my money where my mouth is and bought them for my portfolio.

Should you buy Aviva Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Here’s why they’re among my favourite UK stocks today.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Growth hero

CRH has proved a reliable earnings grower even during tough times. City analysts expect this impressive run to continue — growth of 8% and 11% is predicted for 2026 and 2027 respectively.

The company supplies building materials across the globe, with the US its single largest market (60% of sales). It has significant growth levers to pull, including massive Stateside spending on transport and water infrastructure. Supply chain shake-ups, and the construction of new data centres and renewable energy projects also create major earnings opportunities.

CRH expects annual sales growth to average 7% and 9% between now and 2030. It’s also expecting adjusted EBITDA to leap to 22%-24% by the end of the period. I’m backing it to hit these targets, though difficulties in the US housing market may cause some near-term problems.

Too cheap to ignore?

At 6.6%, Aviva shares carry one of the FTSE 100‘s highest near-term dividend yields. Predictions of further dividend growth in 2027 drive the reading to 7.1% too.

I bought the financial services giant for it passive income qualities. The majority of its operations are capital light in nature. And with its insurance premiums and service fees driving a steady flow of cash, it’s able to return boatloads of capital to its shareholders.

But it isn’t all about dividends at Aviva. With ultra-low price-to-earnings growth (PEG) ratios, it has great appeal as a value share too. For this year and next, its PEG readings are 0.1 and 0.8 respectively. Any reading below 1 is considered bargain-basement territory.

Though its markets are highly competitive, I’m optimistic earnings and dividends will keep rising, driven by rising financial services demand.

8% dividend yield

Primary Health Properties is my favourite all-round dividend share, and last month I increased my holdings. For this year its dividend yield is 7.8%, rising to 8% for 2027. Both figures are more than double the FTSE 100 average of 3%.

These large payouts partly reflect real estate investment trust (REIT) rules, where at least 90% of annual rental profits must go out in dividends. However, it also reflects the company’s focus on the lucrative and ultra-defensive medical sector. With rental rolls guaranteed by government bodies too, and a large proportion also inflation linked, its income streams are rock solid.

Yearly dividends have grown every year since the mid-1990s. Primary Health’s share price could suffer if interest rates rise, hitting asset values. But it’s still one of the best UK shares out there, in my view.

Royston Wild has positions in Aviva Plc, CRH Plc and Primary Health Properties Plc. The Motley Fool UK has recommended Primary Health Properties Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »